Skip to main content
Health Care Professionals
Patients
English
Canada > English
Canada > French
Product Innovation
Product Innovation
Pipeline
Psychiatry
Neurology
Additional Therapies
Scientific Publications
Careers
Careers
Job Search
Benefits
Career Growth
Partnerships
Partnerships
Submission Process
Responsibility
Responsibility
Building Communities
Advocating for Patients
About Us
About Us
Mission, Vision & Values
People & Culture
Executive Leadership
Diversity & Inclusion
Contact Us
News & Media
News & Media
Media Kit
Health Care Professionals
Patients
Press Releases
ENGLISH
US
ENGLISH
EUROPE
ENGLISH
CANADA
ENGLISH
FRENCH
GLOBAL
ENGLISH
Home
Who We Are
Who We are overview
Our Mission, Vision & Values
Executive Leadership
Nobuhiko Tamura
Greg Bokar
Matthew D'Ambrosio
David Frawley
Stephen Freeman
Robert Gregorio
Antony Loebel
Our History
Our People
Jeffrey Akin
Robin Cruz
John Gallo
Katrina Iserman
Henry McMillan
Daniel Yi
Join Us
Join us overview
Benefits
Job Search
Special Programs
General Warning to Job Seekers
Responsibility
Responsibility overview
Patient Support & Advocacy
Community Building
Our Therapies
Oor Therapies Overview
Aptiom
®
(eslicarbazepine acetate) tablets
Brovana
®
(aformoterol tartrate) Inhalation Solution
Latuda
®
(lurasidone HCi) tablets
Lonhala
®
Magnair
®
(glycopyrrolate) Inhalation Solution
Lunesta
®
(eszopiclone) tablets
Xopenex
®
HFA
(levalbuterol tartrate) Inhalation Aerosol
Research & Development
Research & Development overview
Our Pipeline
Psychiatric Disorders Overview
Neurological Disorders Overview
Respiratory Disorders Overview
Research Grants
Disclosure of Clinical Study Data
Explore Partnerships
Explore Partnerships Overview
Our Partners
Partnering Contact Form
Featured News
Health Care Professionals
Our Patients
Media
Contact Us
Follow us on:
Featured News Overview
Press Releases
Press Releases
Search terms
Year